Comparative serum proteomic analysis identified afamin as a downregulated protein in papillary thyroid carcinoma patients with non-131I-avid lung metastases
Authors:
- Yan-Li XueYXYan-Li Xue
- Zhong-Ling QiuZQZhong-Ling Qiu
- Quan-Yong LuoQLQuan-Yong Luo
Open Access
- 1 December 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 34 (12) , 1196-1203
Abstract
The loss of 131I uptake ability in metastases from differentiated thyroid carcinoma (DTC) is becoming a major obstacle in radioiodine treatment. However, there is no effective way to screen for 131I uptake ability in metastases. The identification of differentially expressed proteins by serum proteomics may contribute to our understanding of the mechanisms underlying the dedifferentiation of DTC. Serum samples were obtained from papillary thyroid carcinoma patients with non-131I-avid lung metastases and 131I-avid lung metastases. Differential protein analysis was performed using two-dimensional gel electrophoresis. Candidate protein spots showing differences in expression between the two groups were identified by means of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and were validated by western blotting. We found that afamin is downregulated in the serum of papillary thyroid carcinoma patients with non-131I-avid lung metastases. Afamin may be a potential serum biomarker for early screening of 131I uptake ability in DTC metastases and could therefore be of value in guiding radioiodine treatment decisions.Keywords
This publication has 30 references indexed in Scilit:
- Serum differential proteomics analysis between papillary thyroid cancer patients with 131I-avid and those with non-131I-avid lung metastases.2011
- Efficacy and Survival Analysis of131I Therapy for Bone Metastases from Differentiated Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2011
- Applications of Proteomics to Thyroid Neoplasms: Are We There Yet?Thyroid®, 2010
- Proteomics in Thyroid Tumor ResearchThe Journal of Clinical Endocrinology & Metabolism, 2009
- Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.2008
- Histopathologic characterization of radioactive iodine‐refractory fluorodeoxyglucose‐positron emission tomography‐positive thyroid carcinomaCancer, 2008
- A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancerSurgery, 2006
- Protein analysis on a proteomic scaleNature, 2003
- Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables.1993
- Surgical reintervention for differentiated thyroid cancerBritish Journal of Surgery, 1993